M-ficolin levels are associated with the occurrence of severe infections in patients with haematological cancer undergoing chemotherapy

Por Ameye, L, Paesmans, M, Thiel, S, Jensenius, J C, Aoun, M
Publicado em 2012

Invasive mechanical ventilation in cancer patients: prior non-invasive ventilation is a poor prognostic factor

Por Meert, A, Berghmans, T, Nayer, N, Paesmans, M, Markiewicz, E, Hardy, M, Sculier, J
Publicado em 2010

Effects of induced relative hypoxia during the postoperative period of abdominal oncologic surgery, on hemoglobin and reticulocyte levels: a prospective, randomized controlled clin...

Por Khalife, M, Wiams, K, Ben Aziz, M, Paesmans, M, Balestra, C, Sosnowski, M
Publicado em 2012

P-057 Body Composition (BC), beyond Body Mass Index (BMI) and sarcopenia, has a major prognostic impact on patients with refractory advanced Colorectal Cancer (aCRC)

Por Van Bogaert, C., Vandeputte, C., Ameye, L., Paesmans, M., Guiot, T., Deleporte, A., Charette, N., Hendlisz, A.
Publicado no Ann Oncol (2016)

Ki-67 expression and patients survival in lung cancer: systematic review of the literature with meta-analysis

Por Martin, B, Paesmans, M, Mascaux, C, Berghmans, T, Lothaire, P, Meert, A-P, Lafitte, J-J, Sculier, J-P
Publicado em 2004

Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therap...

Por Cometta, A, Zinner, S, de Bock, R, Calandra, T, Gaya, H, Klastersky, J, Langenaeken, J, Paesmans, M, Viscoli, C, Glauser, M P
Publicado em 1995

The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis

Por Meert, A-P, Paesmans, M, Martin, B, Delmotte, P, Berghmans, T, Verdebout, J-M, Lafitte, J-J, Mascaux, C, Sculier, J-P
Publicado em 2002

The role of HER-2/neu expression on the survival of patients with lung cancer: a systematic review of the literature

Por Meert, A-P, Martin, B, Paesmans, M, Berghmans, T, Mascaux, C, Verdebout, J-M, Delmotte, P, Lafitte, J-J, Sculier, J-P
Publicado em 2003

Has Cox-2 a prognostic role in non-small-cell lung cancer? A systematic review of the literature with meta-analysis of the survival results

Por Mascaux, C, Martin, B, Paesmans, M, Berghmans, T, Dusart, M, Haller, A, Lothaire, P, Meert, A-P, Lafitte, J-J, Sculier, J-P
Publicado em 2006

The current use and attitudes towards tumor genome sequencing in breast cancer

Por Gingras, I., Sonnenblick, A., de Azambuja, E., Paesmans, M., Delaloge, S., Aftimos, Philippe, Piccart, M. J., Sotiriou, C., Ignatiadis, M., Azim, H. A.
Publicado no Sci Rep (2016)

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12 155 patients

Por de Azambuja, E, Cardoso, F, de Castro, G, Colozza, M, Mano, M S, Durbecq, V, Sotiriou, C, Larsimont, D, Piccart-Gebhart, M J, Paesmans, M
Publicado em 2007

The role of RAS oncogene in survival of patients with lung cancer: a systematic review of the literature with meta-analysis

Por Mascaux, C, Iannino, N, Martin, B, Paesmans, M, Berghmans, T, Dusart, M, Haller, A, Lothaire, P, Meert, A-P, Noel, S, Lafitte, J-J, Sculier, J-P
Publicado em 2005

The role of mitomycin in the treatment of non-small cell lung cancer: a systematic review with meta-analysis of the literature

Por Sculier, J P, Ghisdal, L, Berghmans, T, Branle, F, Lafitte, J J, Vallot, F, Meert, A P, Lemaitre, F, Steels, E, Burniat, A, Mascaux, C, Paesmans, M
Publicado em 2001

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

Por Martin, B, Paesmans, M, Berghmans, T, Branle, F, Ghisdal, L, Mascaux, C, Meert, A-P, Steels, E, Vallot, F, Verdebout, J-M, Lafitte, J-J, Sculier, J-P
Publicado em 2003

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients

Por Pujol, J-L, Molinier, O, Ebert, W, Daurès, J-P, Barlesi, F, Buccheri, G, Paesmans, M, Quoix, E, Moro-Sibilot, D, Szturmowicz, M, Bréchot, J-M, Muley, T, Grenier, J
Publicado em 2004

Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell...

Por Sculier, J-P, Lafitte, J-J, Paesmans, M, Thiriaux, J, Alexopoulos, C G, Baumöhl, J, Schmerber, J, Koumakis, G, Florin, M C, Zacharias, C, Berghmans, T, Mommen, P, Ninane, V, Klastersky, J
Publicado em 2000

Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party

Por Berghmans, T, Lafitte, J J, Lecomte, J, Alexopoulos, C G, Van Cutsem, O, Giner, V, Efremidis, A, Berchier, M C, Collon, T, Meert, A P, Scherpereel, A, Ninane, V, Leclercq, N, Paesmans, M, Sculier, J P
Publicado em 2007

A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor o...

Por Sculier, J P, Paesmans, M, Lecomte, J, Van Cutsem, O, Lafitte, J J, Berghmans, T, Koumakis, G, Florin, M C, Thiriaux, J, Michel, J, Giner, V, Berchier, M C, Mommen, P, Ninane, V, Klastersky, J
Publicado em 2001

Clinical significance of CD73 in triple-negative breast cancer: multiplex analysis of a phase III clinical trial

Por Buisseret, L, Pommey, S, Allard, B, Garaud, S, Bergeron, M, Cousineau, I, Ameye, L, Bareche, Y, Paesmans, M, Crown, J P A, Di Leo, A, Loi, S, Piccart-Gebhart, M, Willard-Gallo, K, Sotiriou, C, Stagg, J
Publicado no Ann Oncol (2018)

Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimi...

Por Cometta, A, Calandra, T, Gaya, H, Zinner, S H, de Bock, R, Del Favero, A, Bucaneve, G, Crokaert, F, Kern, W V, Klastersky, J, Langenaeken, I, Micozzi, A, Padmos, A, Paesmans, M, Viscoli, C, Glauser, M P
Publicado em 1996